Latest Renewables News

Calix Limited has secured a $44.9 million grant from ARENA to build a pioneering Green Iron Demonstration Plant using its ZESTY technology, aiming to produce 30,000 tonnes of low-emission iron annually and advance Australia’s green steel ambitions.

Lynas Rare Earths has achieved record quarterly production of key rare earth elements and reported a strong 38% increase in sales revenue, while advancing its Mt Weld expansion and signing strategic MOUs in Malaysia.

St Barbara Limited is progressing towards the renewal of its Simberi Mining Lease, a critical step to extend operations and boost gold production through 2038. Final approval is anticipated in August 2025 after regulatory review delays.

St Barbara Limited updates on its Nova Scotia operations with progress on the 15-Mile Processing Hub prefeasibility study, reclamation milestones at Touquoy, and a pioneering pumped hydro energy storage project, while weighing strategic options for its Atlantic Gold assets.

Cyclone Metals reports strong progress on its Iron Bear Project, highlighting a completed renewable energy power study and successful metallurgical test results that underpin its sustainable mining ambitions.

Lincoln Minerals Limited has unveiled a comprehensive update on its critical minerals projects in South Australia’s Gawler Craton, highlighting imminent drilling approvals at the Minbrie copper-base metals project and strong progress across graphite, uranium, and high purity iron assets.

Rimfire Pacific Mining Limited has had its trading suspension lifted immediately following the release of its capital raising results, signaling renewed market activity.

Rimfire Pacific Mining has secured $3.5 million through a discounted share placement to accelerate scandium resource development across its NSW projects, signaling renewed momentum after arbitration setbacks.

Astute Metals NL sharpens its focus on Nevada’s rich mineral landscape, unveiling fresh high-grade gold targets at Needles and reaffirming lithium potential at Red Mountain amid leadership changes.

Amplia Therapeutics has successfully raised A$25 million through an institutional placement and launched a A$2.5 million Share Purchase Plan to fund pivotal clinical trials of its lead drug narmafotinib. The capital injection positions the company to advance key pancreatic and ovarian cancer studies into 2027.

Aerometrex has completed a strategic review that delivers $2 million in cost savings and initiates data monetisation, positioning the company for accelerated growth in FY26.

Highfield Resources has entered a significant non-binding agreement with China’s Qinghai Salt Lake Industry for a US$300 million equity injection, aiming to fast-track its Muga potash mine development and expand its global footprint.